29 Oct 2026 · 2 min read
I said Anthropic would carry no drug asset. I was wrong
In IPO week, Anthropic disclosed a drug program it bought from Mithril Medicine, a one-person startup. Here is what that changes in my August prediction, and what still holds for pharma.